Formulations and use of a beta-blocker and an ACE-inhibitor for the treatment of cardiovascular diseases
OwnerTemple Okarter, Richard Aiena +1inventors
InventorsTemple Okarter, Richard Aiena, Bhudev Sharma
Life of this patent
Estimating the term…
Loading patent…
OwnerTemple Okarter, Richard Aiena +1inventors
InventorsTemple Okarter, Richard Aiena, Bhudev Sharma
Estimating the term…
The use of a beta-blocker and an ACE-inhibitor in combination for the treatment of cardiovascular disorders, including hypertension and congestive heart failure, is provided. In particular, pharmaceutical formulations which use metoprolol tartrate and enalapril maleate in a therapeutically effective combination in a single extended release dosing unit for the treatment of congestive heart failure are disclosed as well as methods of using those formulations, thereby resulting in a decrease in a patient's overall pill burden.
A method of using a beta-blocker and an ACE-inhibitor in combination for the treatment of cardiovascular disorders comprising:
A method of using metoprolol tartrate or pharmaceutically acceptable salts thereof and enalapril maleate or pharmaceutically acceptable salts thereof in combination for the treatment of cardiovascular disorders comprising:
An extended release dosage unit for use in the treatment of cardiovascular disorders comprising a core section and an outer section;
A method of reducing a patient's pill burden in the treatment of cardiovascular disorders comprising:
A single dosage unit for use in the treatment of cardiovascular disorders comprising a core section and a pharmaceutically acceptable outer section;
Dependencies are inferred from the claim text.